Legacy of Hope: How Planned Giving to the Cancer Research Institute Propels Immunotherapy Towards a Cancer-Immune World
admin Including the Cancer Research Institute (CRI) in one’s will represents a profound personal commitment to...
biotech
Eli Lilly Delays Retatrutide Filing, Triple-G Drug Poised to Reshape Obesity Market Amidst Cardiovascular Questions
Eli Lilly and Company, a global pharmaceutical leader, has announced a revised timeline for the...
July Marks Ultraviolet Radiation Safety Awareness Month: A Deep Dive into Skin Cancer Prevention and Immunotherapy Breakthroughs
As July unfolds, the Cancer Research Institute (CRI) joins health organizations worldwide in observing Ultraviolet...
Potential Tariffs on Generic Pharmaceuticals Threaten Widespread Disruption to U.S. Healthcare System
The prospect of significant tariffs, potentially reaching up to 200%, on imported generic pharmaceuticals poses...
GSK Secures Landmark FDA Approval for Jideytro in ROS1-Positive Lung Cancer, Solidifying Its Ambitious Oncology Expansion
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Jideytro, a novel...
Vertex Pharmaceuticals’ $10 Billion Crinetics Acquisition Sparks Investor Debate Over Valuation Amidst Lone Bidder Scenario
Boston, MA – Vertex Pharmaceuticals, a biotechnology giant primarily known for its groundbreaking cystic fibrosis...
Arrowhead hits ‘best-case scenario’ with latest results for fat-lowering drug
A genetic medicine developed by Arrowhead Pharmaceuticals, known as plozasiran, has demonstrated compelling success in...
Crystalys Therapeutics Secures $130 Million Series B Funding to Accelerate Global Gout Treatment Program.
Emerging biotech firm Crystalys Therapeutics has announced a substantial $130 million Series B financing round,...
Novartis Navigates Critical Juncture with Q2 Sales Growth Amidst Looming Patent Cliffs and High-Stakes Pipeline Readouts
Novartis AG, the Swiss pharmaceutical giant, experienced a significant surge in its share price on...
Introducing the 2026 CRI Lloyd J. Old STARs: Five Scientists Shaping the Future of Cancer Immunotherapy
The Cancer Research Institute (CRI) has proudly announced the selection of its 2026 class of...
